Carroll PR - Search Results

1

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.

Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, Jenkins RB, Davicioni E, Ross AE, Schaeffer EM, Nguyen PL, Carroll PR, Karnes RJ, Spratt DE, Feng FY. Zhao SG, et al. Among authors: carroll pr. JAMA Oncol. 2017 Dec 1;3(12):1663-1672. doi: 10.1001/jamaoncol.2017.0751. JAMA Oncol. 2017. PMID: 28494073 Free PMC article.

2

High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.

Cher ML, Shinohara K, Breslin S, Vapnek J, Carroll PR. Cher ML, et al. Among authors: carroll pr. Br J Urol. 1995 Jun;75(6):771-7. doi: 10.1111/j.1464-410x.1995.tb07389.x. Br J Urol. 1995. PMID: 7542137 Clinical Trial.

3

Focal therapy for prostate cancer 1996: maximizing outcome.

Carroll PR, Presti JC Jr, Small E, Roach M 3rd. Carroll PR, et al. Urology. 1997 Mar;49(3A Suppl):84-94. doi: 10.1016/s0090-4295(97)00174-x. Urology. 1997. PMID: 9123742 Review.

4

Intermittent androgen deprivation for clinically localized prostate cancer: initial experience.

Grossfeld GD, Small EJ, Carroll PR. Grossfeld GD, et al. Among authors: carroll pr. Urology. 1998 Jan;51(1):137-44. doi: 10.1016/s0090-4295(97)00488-3. Urology. 1998. PMID: 9457309 Clinical Trial.

5

Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer.

Grossfeld GD, Chaudhary UB, Reese DM, Carroll PR, Small EJ. Grossfeld GD, et al. Among authors: carroll pr. Urology. 2001 Aug;58(2):240-5. doi: 10.1016/s0090-4295(01)01114-1. Urology. 2001. PMID: 11489710

6

Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy.

Grossfeld GD, Small EJ, Lubeck DP, Latini D, Broering JM, Carroll PR. Grossfeld GD, et al. Among authors: carroll pr. Urology. 2001 Aug;58(2 Suppl 1):56-64. doi: 10.1016/s0090-4295(01)01243-2. Urology. 2001. PMID: 11502450 Review.

7

Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.

Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll PR, Tlsty TD. Meng MV, et al. Among authors: carroll pr. Clin Cancer Res. 2001 Sep;7(9):2712-8. Clin Cancer Res. 2001. PMID: 11555583

8

Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.

Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR. Cooperberg MR, et al. Among authors: carroll pr. J Urol. 2002 Aug;168(2):491-5. J Urol. 2002. PMID: 12131295

9

Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer.

Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. Meng MV, et al. Among authors: carroll pr. Urology. 2002 Sep;60(3 Suppl 1):7-11; discussion 11-2. doi: 10.1016/s0090-4295(02)01560-1. Urology. 2002. PMID: 12231037

10

How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR; CaPSURE. Cooperberg MR, et al. Among authors: carroll pr. Urology. 2003 Jan;61(1):190-6. doi: 10.1016/s0090-4295(02)02118-0. Urology. 2003. PMID: 12559294 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

828 results

Search Page

Filters